WORK Medical Technology Group LTD (WOK) Income Statement
WOK FY2025 at a glance
Fiscal year ended September 30, 2025 · U.S. dollarsWOK revenue and net income
Where WOK's revenue goes
FY2025Each bar shows an amount and its share of revenue. WOK kept −10.9% of revenue as net income.
WOK profit margins
WOK growth rates
to FY2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −14.4% | −20.6% | −28.5% | — |
| Gross profit | −18.3% | −19.0% | −26.4% | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
WOK quarterly EPS vs estimates
WORK Medical Technology Group LTD beat the analyst EPS estimate in 1 of the last 2 quarters.
WOK income statement
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Revenue | $9.8M | $11.5M | $13.6M | $19.7M | $45.9M | $52.5M |
| Cost of revenue | $7.5M | $8.6M | $9.4M | $15.3M | $37.2M | $41.7M |
| Gross profit | $2.3M | $2.9M | $4.1M | $4.4M | $8.6M | $10.8M |
| Research & development | $435,311 | $302,511 | $301,644 | $183,900 | $186,446 | $797,382 |
| Sales, general & admin | $4.4M | $4.6M | $1.9M | $2.6M | $2.9M | $2.8M |
| Total operating expenses | $4.8M | $6.6M | $3.7M | $2.6M | $965,339 | $4.9M |
| Operating income | −$2.5M | −$3.7M | $486,459 | $1.8M | $7.7M | $6.0M |
| Interest income | $181,682 | $11,727 | $25,417 | $1,969 | — | — |
| Interest expense | $503,519 | $557,571 | $367,323 | $350,999 | $329,517 | $260,025 |
| Income before taxes | −$1.1M | −$3.7M | $110,389 | $1.1M | $7.3M | $1.3M |
| Income taxes | $119,053 | −$125,291 | $47,006 | $169,435 | $1.1M | $108,916 |
| Net income | −$1.1M | −$3.5M | $112,030 | $865,210 | $6.0M | $1.2M |
| EBITDA | $339,372 | −$1.7M | $2.1M | $4.7M | $11.9M | $4.7M |
| EPS (diluted) | −$10.35 | −$0.24 | $0.01 | $0.07 | — | — |
| Gross margin | 23.8% | 24.9% | 30.5% | 22.4% | 18.8% | 20.7% |
| Operating margin | −25.3% | −32.1% | 3.6% | 9.3% | 16.7% | 11.4% |
| Net margin | −10.9% | −30.4% | 0.8% | 4.4% | 13.0% | 2.2% |
| Jun '26 | Dec '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | Mar '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.4M | $5.3M | $2.3M | $4.5M | $2.3M | $6.2M | $3.1M | $5.3M | $2.7M | $4.6M | $2.3M | $9.0M |
| Cost of revenue | $4.9M | $4.5M | $1.5M | $3.0M | $1.5M | $4.9M | $2.4M | $3.8M | $1.9M | $4.3M | $2.2M | $5.1M |
| Gross profit | $530,349 | $782,557 | $781,149 | $1.6M | $781,149 | $1.3M | $662,703 | $1.5M | $771,490 | $242,918 | $121,459 | $3.9M |
| Research & development | $98,670 | $182,229 | $126,540 | $253,080 | $126,540 | $123,728 | $61,864 | $178,784 | $89,392 | $70,632 | $35,316 | $231,012 |
| Sales, general & admin | — | $1.5M | $1.4M | $2.9M | $1.4M | $4.7M | $2.4M | $1.9M | $935,945 | $1.7M | $846,193 | $1.1M |
| Total operating expenses | $4.1M | $1.7M | $1.6M | $3.1M | $1.6M | $4.9M | $2.4M | $2.1M | $1.0M | $1.8M | $881,509 | $1.9M |
| Operating income | −$3.5M | −$929,692 | −$783,183 | −$1.6M | −$783,183 | −$3.5M | −$1.8M | −$507,694 | −$253,847 | −$1.5M | −$760,050 | $2.0M |
| Interest expense | $117,902 | $216,692 | $286,827 | $286,827 | — | $293,358 | — | $252,486 | — | $221,244 | — | $367,323 |
| Income before taxes | −$3.5M | −$960,794 | −$121,176 | −$242,352 | −$60,588 | −$3.6M | −$2.0M | $254,904 | $127,452 | −$1.2M | −$771,823 | $1.3M |
| Income taxes | −$153 | $210,804 | −$91,751 | −$183,502 | $45,876 | $145,342 | $72,671 | $20,050 | $10,025 | $173,666 | $86,833 | −$126,660 |
| Net income | −$3.4M | −$1.1M | $6,578 | $13,156 | $6,578 | −$3.7M | −$1.9M | $226,526 | $113,263 | −$1.4M | −$681,852 | $1.5M |
| EBITDA | −$3.0M | −$157,983 | −$617,333 | −$1.2M | −$617,333 | −$2.9M | −$1.4M | $200,606 | $100,303 | −$625,554 | −$312,777 | $2.7M |
| EPS (diluted) | — | — | $0.09 | — | −$0.29 | — | — | — | — | — | — | — |
| Gross margin | 9.8% | 14.8% | 34.4% | 34.4% | 34.4% | 21.4% | 21.4% | 29.1% | 29.1% | 5.3% | 5.3% | 43.3% |
| Operating margin | −65.3% | −17.5% | −34.5% | −34.5% | −34.5% | −57.1% | −57.1% | −9.6% | −9.6% | −33.4% | −33.4% | 22.3% |
| Net margin | −63.0% | −20.5% | 0.3% | 0.3% | 0.3% | −60.0% | −60.0% | 4.3% | 4.3% | −29.9% | −29.9% | 16.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in WOK's financial statements (latest annual report filed January 30, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
WOK financial results
In fiscal year 2025 (ended September 30, 2025), WORK Medical Technology Group LTD reported revenue of $9.8 million, down 14.4% from the year before. It had a net loss of $1.1 million, a net profit margin of −10.9%. Diluted earnings per share came to −$10.35. Over five years revenue grew at an average rate of −28.5% a year.
See the WOK stock overview for the latest quote and news, or the WOK chart for price history and technical indicators.
WOK income statement FAQ
What is WORK Medical Technology Group LTD's annual revenue?
WORK Medical Technology Group LTD reported total revenue of $9.8 million for fiscal year 2025, which ended on September 30, 2025. That was down 14.4% from $11.5 million the previous year.
Is WORK Medical Technology Group LTD profitable?
No. WORK Medical Technology Group LTD reported a net loss of $1.1 million in fiscal 2025, a net profit margin of −10.9%; its operating margin was −25.3%.
What is WORK Medical Technology Group LTD's gross margin?
WORK Medical Technology Group LTD's gross margin was 23.8% in fiscal 2025: for every $100 of revenue, WORK Medical Technology Group LTD kept $24 after the direct cost of its products and services.
How much does WORK Medical Technology Group LTD spend on research and development?
WORK Medical Technology Group LTD spent $0.4 million on research and development in fiscal 2025, 4.4% of revenue.
How fast is WORK Medical Technology Group LTD growing?
Revenue grew −28.5% a year on average over the last five fiscal years, from $52.5 million to $9.8 million.
What are WORK Medical Technology Group LTD's earnings per share?
WORK Medical Technology Group LTD earned $-10.35 per diluted share in fiscal 2025, compared with $-0.24 a year earlier.
When does WORK Medical Technology Group LTD's fiscal year end?
WORK Medical Technology Group LTD's fiscal year ends in September. The latest annual report covers the year ended September 30, 2025 and was filed on January 30, 2026.